Medical Aesthetics Overview

Driven by world-class research and development and built on more than 20 years of pharmaceutical experience, Endo is working to develop the aesthetic solutions of tomorrow in order to enhance physicians’ practices and to help patients feel better about their bodies.

This includes the development of a new investigational injectable for cellulite, a contour alteration of the skin that has been reported in 85 to 98 percent of post-pubertal females.

Learn more about Cellulite.

About Endo


Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.


You are now leaving the website

Cancel Continue